Antimicrobial, Probiotic, and Immunomodulatory Potential of Cannabis sativa Extract and Delivery Systems

Anna Stasiłowicz-Krzemień,Daria Szymanowska,Piotr Szulc,Judyta Cielecka-Piontek

DOI: https://doi.org/10.3390/antibiotics13040369

2024-04-18

Antibiotics

Abstract:The compounds present in hemp show multidirectional biological activity. It is related to the presence of secondary metabolites, mainly cannabinoids, terpenes, and flavonoids, and the synergy of their biological activity. The aim of this study was to assess the activity of the Henola Cannabis sativae extract and its combinations with selected carriers (polyvinyl caprolactam–polyvinyl acetate–polyethylene glycol graft copolymer, magnesium aluminometasilicate, and hydroxypropyl-β-cyclodextrin) in terms of antimicrobial, probiotic, and immunobiological effects. As a result of the conducted research, the antimicrobial activity of the extract was confirmed in relation to the following microorganisms: Clostridium difficile, Listeria monocytogenes, Enterococcus faecalis, Staphylococcus aureus, Staphylococcus pyrogenes, Escherichia coli, Klebsiella pneumoniae, Salmonella typhimurium, Pseudomonas aereuginosa, and Candida albicans (microorganism count was reduced from ~102 CFU mL−1 to <10 CFU mL−1 in most cases). Additionally, for the system with hydroxypropyl-β-cyclodextrin, a significant probiotic potential against bacterial strains was established for strains Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus brevis, Lactobacillus rhamnosus, Lactobacillus reuteri, Pediococcus pentosaceus, Lactococcus lactis, Lactobacillus fermentum, and Streptococcus thermophilus (microorganism count was increased from ~102 to 104–107). In terms of immunomodulatory properties, it was determined that the tested extract and the systems caused changes in IL-6, IL-8, and TNF-α levels.

pharmacology & pharmacy,infectious diseases

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on evaluating the antibacterial, prebiotic and immunomodulatory potentials of Cannabis sativa extracts and their combinations with selected carriers. Specifically:

1. **Antibacterial activity**: The research aims to verify the antibacterial effects of Henola Cannabis sativa extract (HiE) and its combinations with different carriers (polyvinylcaprolactam - polyvinyl acetate - polyethylene glycol graft copolymer, magnesium aluminum silicate and hydroxypropyl - β - cyclodextrin). The research objects include a variety of potentially pathogenic microorganisms, such as Clostridium difficile, Listeria monocytogenes, Enterococcus faecalis, Staphylococcus aureus, Staphylococcus pyrogenes, Escherichia coli, Klebsiella pneumoniae, Salmonella typhimurium, Pseudomonas aeruginosa and Candida albicans.

2. **Prebiotic potential**: The research also evaluates the effects of these systems on probiotic strains, especially the significant prebiotic potential of the hydroxypropyl - β - cyclodextrin system. The probiotic strains tested include Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus brevis, Lactobacillus rhamnosus, Lactobacillus reuteri, Pediococcus pentosaceus, Lactococcus lactis, Lactobacillus fermentum and Streptococcus thermophilus.

3. **Immunomodulatory and immunostimulatory effects**: The research further explores the potentials of these systems in immunomodulation and immunostimulation. Through in - vitro experiments, the effects of these systems on the levels of cytokines (such as IL - 6, IL - 8 and TNF - α) produced by Caco - 2 cells are studied. The experimental design includes applying these systems before and after inflammation induction to evaluate their protective and therapeutic effects.

In conclusion, this paper aims to comprehensively evaluate the potentials of Henola Cannabis sativa extract and its different carrier combinations in antibacterial, prebiotic and immunomodulatory aspects, and provide a scientific basis for the development of new antibacterial agents, prebiotics and immunomodulators.